Quality, Training, Research and Artificial Intelligence for Healthcare

We simplify quality management and information security through methods, proprietary tools and continuing education

ICMED S.r.l. is a private company based in Italy, founded in 2017, offering research, training and consulting services for research centres, stem cell transplant programs, gene therapy centres, fertility centres and hospitals. We are present on three continents (Europe, Africa and the Middle East) and serve over 100 clients.

20+ Years of experience
100+ Clients served
500+ Trained professionals
3 Continents

ICMED Consulting

JACIE/FACT accreditation, CAR-T consulting, PMA programmes, ISO 15189, transfusion services and more. We support healthcare facilities, research centres and pharmaceutical companies across 3 continents.

Book a strategy consultation
Our expertise
JACIE/FACT CAR-T CNT/CNS ISO 15189 PMA GMP/GCP ISO 9001 ISO 27001 UNI/PdR 125

Why ICMED

Certifications, accreditations and a consistent growth path since 2017

100% Inspection success rate
41 Facilities supported
5 Countries
28+ Update courses delivered
Provider ECM 7158 ISO 9001:2015 ISO/IEC 27001:2024 UNI/PdR 125:2022 ISSN 3103-1943 ACN QC1 (in progress) 12+ publications and EBMT/ASH congresses →
2017

ICMED S.r.l. founded — consulting for Transplant Programmes, CAR-T, PMA, JACIE/FACT, GCP and GMP accreditation

2019

Launch of training pathways for Transfusion Services, Cell Therapy, Phase 1 Centres and PMA. First qualification programmes

2022

Qualified as provisional national ECM Provider with AGENAS ID 7158

2023

Launch of the quality management platform — IAAPP

2024

Middle East market entry: Qatar, UAE, Kuwait

2025

Launch of ICMEDU365 e-learning platform. ICMED Magazine founded

2026

ISSN 3103-1943 for ICMED Magazine. Definitive ECM Provider. ISO/IEC 27001:2024 and UNI/PdR 125:2022 certifications

News & Activities

Latest news and scientific activities

TransMedics and Mercedes-Benz: Italy's First Dedicated Organ Transplantation Ground Transportation Network
News

TransMedics and Mercedes-Benz: Italy's First Dedicated Organ Transplantation Ground Transportation Network

The ICMED perspective

This collaboration strengthens critical traceability and quality control infrastructure for organ transplantation, directly supporting compliance with ISO 15189 and JACIE standards requiring documented chain-of-custody protocols. Facilities can now leverage dedicated, validated transportation networks to enhance safety records and regulatory documentation essential for accreditation audits.

Cellular Therapy in Mantle Cell Lymphoma: EBMT 2026 Recommendations
Publications

Cellular Therapy in Mantle Cell Lymphoma: EBMT 2026 Recommendations

The ICMED perspective

These harmonised EBMT recommendations provide critical standardisation for CAR-T cellular therapy protocols, enabling facilities to align their quality management systems with international best practices and maintain JACIE compliance while improving patient safety outcomes in mantle cell lymphoma treatment.

EBMT 2024 Report: One Million Transplants and 20,000 CAR-T Therapies, a Cellular Medicine Milestone
Publications

EBMT 2024 Report: One Million Transplants and 20,000 CAR-T Therapies, a Cellular Medicine Milestone

The ICMED perspective

This milestone underscores the necessity of rigorous JACIE accreditation and quality standards for cellular therapy programs. Facilities must implement stringent compliance frameworks to maintain patient safety and therapeutic efficacy while scaling advanced CAR-T and transplant operations.

View all activities

Scientific Insights & Magazine

ICMED Magazine (ISSN 3103-1943) — the scientific journal dedicated to quality and innovation in healthcare

All Magazine issues

Contact